HRS-1358

HRS-1358 · Shandong Suncadia Medicine Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for HRS-1358, covering 2025-03-17 to 2026-03-02. Get the full timeline:

Most recent: Clinical Trial Update: A Trial of HRS-2189 in Combination With Fluvastatin±HRS-6209, or HRS-8080±HRS-6209, or HRS-6209+HRS-1358 in Breast Cancer Patients [Phase 1, Phase 2]

See pricing